000 01269 a2200349 4500
005 20250516043159.0
264 0 _c20121011
008 201210s 0 0 eng d
022 _a1460-2393
024 7 _a10.1093/qjmed/hcr094
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTran, H A
245 0 0 _aThe adjuvant role of thyroxine in the treatment of chronic hepatitis C infection.
_h[electronic resource]
260 _bQJM : monthly journal of the Association of Physicians
_cJul 2012
300 _a683-7 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAntiviral Agents
_xadverse effects
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xadverse effects
650 0 4 _aMiddle Aged
650 0 4 _aRibavirin
_xtherapeutic use
650 0 4 _aThyroid Diseases
_xchemically induced
650 0 4 _aThyroxine
_xtherapeutic use
700 1 _aIanna, E A
700 1 _aJones, T L
700 1 _aReeves, G E M
773 0 _tQJM : monthly journal of the Association of Physicians
_gvol. 105
_gno. 7
_gp. 683-7
856 4 0 _uhttps://doi.org/10.1093/qjmed/hcr094
_zAvailable from publisher's website
999 _c20944482
_d20944482